AKAN
Price
$0.17
Change
+$0.04 (+30.77%)
Updated
May 17, 6:59 PM EST
QLI
Price
$0.68
Change
-$0.01 (-1.45%)
Updated
May 17, 6:59 PM EST
Ad is loading...

AKAN vs QLI

Header iconAKAN vs QLI Comparison
Open Charts AKAN vs QLIBanner chart's image
Akanda
Price$0.17
Change+$0.04 (+30.77%)
Volume$291.29M
CapitalizationN/A
Qilian International Holding Group
Price$0.68
Change-$0.01 (-1.45%)
Volume$905
CapitalizationN/A
View a ticker or compare two or three
AKAN vs QLI Comparison Chart

Loading...

AKANDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
AKAN vs. QLI commentary
May 20, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKAN is a Hold and QLI is a Hold.

COMPARISON
Comparison
May 20, 2024
Stock price -- (AKAN: $0.17 vs. QLI: $0.68)
Brand notoriety: AKAN and QLI are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AKAN: 2132% vs. QLI: 1%
Market capitalization -- AKAN: $1.25M vs. QLI: $24.66M
AKAN [@Pharmaceuticals: Other] is valued at $1.25M. QLI’s [@Pharmaceuticals: Other] market capitalization is $24.66M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $2.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AKAN’s FA Score shows that 0 FA rating(s) are green whileQLI’s FA Score has 1 green FA rating(s).

  • AKAN’s FA Score: 0 green, 5 red.
  • QLI’s FA Score: 1 green, 4 red.
According to our system of comparison, both AKAN and QLI are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AKAN’s TA Score shows that 4 TA indicator(s) are bullish.

  • AKAN’s TA Score: 4 bullish, 4 bearish.

Price Growth

AKAN (@Pharmaceuticals: Other) experienced а +75.76% price change this week, while QLI (@Pharmaceuticals: Other) price change was -6.62% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.80%. For the same industry, the average monthly price growth was +5.61%, and the average quarterly price growth was +19185.52%.

Reported Earning Dates

AKAN is expected to report earnings on May 02, 2022.

QLI is expected to report earnings on Apr 19, 2023.

Industries' Descriptions

@Pharmaceuticals: Other (+2.80% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
A.I.dvisor published
a Summary for AKAN with price predictions.
OPEN
A.I.dvisor published
a Summary for QLI with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
QLI($24.7M) has a higher market cap than AKAN($1.25M). QLI YTD gains are higher at: -11.641 vs. AKAN (-60.813). QLI has higher annual earnings (EBITDA): 3.28M vs. AKAN (-3.86M). QLI has more cash in the bank: 11.9M vs. AKAN (3.93M). AKAN has less debt than QLI: AKAN (3.83M) vs QLI (13M). QLI has higher revenues than AKAN: QLI (59.2M) vs AKAN (111K).
AKANQLIAKAN / QLI
Capitalization1.25M24.7M5%
EBITDA-3.86M3.28M-118%
Gain YTD-60.813-11.641522%
P/E RatioN/A15.98-
Revenue111K59.2M0%
Total Cash3.93M11.9M33%
Total Debt3.83M13M29%
TECHNICAL ANALYSIS
Technical Analysis
AKAN
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
85%
Momentum
ODDS (%)
Bullish Trend 3 days ago
90%
MACD
ODDS (%)
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
88%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
AKANDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HOOK0.82N/A
+0.54%
HOOKIPA Pharma
IVR9.410.01
+0.11%
Invesco Mortgage Capital
LYFT16.62-0.33
-1.95%
Lyft
AKRO.X0.006815-0.000173
-2.47%
Akropolis cryptocurrency
KROS52.28-1.71
-3.17%
Keros Therapeutics

AKAN and

Correlation & Price change

A.I.dvisor tells us that AKAN and CGC have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AKAN and CGC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AKAN
1D Price
Change %
AKAN100%
+30.26%
CGC - AKAN
32%
Poorly correlated
-1.36%
ACB - AKAN
29%
Poorly correlated
-3.02%
OGI - AKAN
28%
Poorly correlated
-0.49%
CRON - AKAN
27%
Poorly correlated
-3.97%
SNOA - AKAN
25%
Poorly correlated
-5.60%
More

QLI and

Correlation & Price change

A.I.dvisor tells us that QLI and SXTC have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that QLI and SXTC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QLI
1D Price
Change %
QLI100%
-4.80%
SXTC - QLI
28%
Poorly correlated
+6.48%
HCM - QLI
22%
Poorly correlated
-3.77%
AKAN - QLI
21%
Poorly correlated
+30.26%
YCBD - QLI
21%
Poorly correlated
+0.74%
UPC - QLI
6%
Poorly correlated
+3.19%
More